Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical CBD for Musculoskeletal Pain
NCT05170451Phase 3Withdrawn
- Sponsor
- University of Virginia
- Start
- Jan 2022
- Primary completion
- Jun 2022
- Countries
- 1
01
Overview
A Phase 3 trial of Zygel in Musculoskeletal pain, sponsored by University of Virginia. Planned start Jan 2022; status: withdrawn.
02
Drugs
Zygel
03
Conditions
Musculoskeletal pain
Beyond the preview
Go deeper on NCT05170451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05170451.